The purpose of this trial is to find out if the study drug can be used to improve symptoms of generalized anxiety disorder.

We are looking for subjects between 18 and 65 years old.

Requirements

• You will be taking the study drug, PD0332334, at a dose of 350 mg, 450 mg, or 600 mg, or a placebo.
• Subjects cannot take antidepressants or antianxiety medications other than study drug during their participation.
• The study lasts up to 10 weeks once enrolled and requires nine visits to Duke.

Compensation